AZ7550, an Active Metabolite of AZD9291 (EGFR TKI), Inhibits the Activity of IGF1R
Lung cancer still remains the most common cancer-related mortality worldwide with about 80-85% of patients suffering from non-small cell lung cancer (NSCLC). The EGFR is currently the most established molecular…